Latest

    Neuromodulation

    Spinal cord stimulation and other modalities will benefit from greater understanding...

    Intraoperative neuromonitoring may drive a new era in spinal cord stimulation...

    Intermittent stimulation of the DRG produces comparable chronic pain results to...

    Why responsive neurostimulation is garnering “wide interest” from the epilepsy field

    HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial

    women neuromodulation update

    Progress update on Women in Neuromodulation: Achievements and obstacles

    Randomised data support use of tDCS in Parkinson’s patients with Pisa...

    Current literature suggests promise held by electrical stimulation therapies for cerebral...

    Neuromodulation offers hope for patients with long-COVID

    INS 2022: Late-breaking research indicates safety of deep brain stimulation in...

    INS 2022: Occipital nerve stimulation shows clinical benefit and safety in...

    tdcs autism

    Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients

    INS 2022: Dorsal horn dendrite stimulation offers “true breakthrough” in pain...

    Neuromodulation for post-stroke recovery advancing on several fronts

    Recommended use of SCS in neuropathic pain has not led to...

    senza-nsrbp

    High-frequency SCS drives impactful outcomes for non-surgical refractory back pain patients

    Lower frequencies may improve outcomes of pain treatment with dorsal root...

    AI, cost reductions and more represent bright future for neuromodulation industry

    Multiple-modality spinal cord stimulation demonstrates sustained improvement in chronic pain outcomes

    Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...

    senza-pdn study

    NANS 2022: New 18-month data show durability of high-frequency SCS for...

    telehealth neuromodulation

    NANS 2022: Telehealth to play key role in improving patient access...

    saint depression treatment

    Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression

    paediatric deep brain stimulation

    Patient assent and lack of evidence among key ethical concerns identified...

    spinal cord stimulation patient access

    Current gaps and barriers in patient access to spinal cord stimulation

    Passive recharge burst SCS provides sustainable improvements in pain and psychosocial...

    scs surgical infection

    Antibiotic envelopes appear safe and effective in decreasing SCS surgical site...

    scs diabetic neuropathy

    High-frequency SCS takes the stage to relieve chronic pain from diabetic...

    crisp study scs

    CRISP study indicates clinical benefit of non-paraesthesia-based approaches in burst SCS...

    dtm scs therapy

    DTM SCS: A unique, tailored and highly effective therapy option for...

    Temporary SCS could represent “new paradigm” in preventing atrial fibrillation

    dbs long-term effectiveness

    Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study

    tdcs mental health treatment

    How stimulation is changing the future of mental health treatment

    spinal cord stimulation men women

    Men and women respond equally well to spinal cord and DRG...

    Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...

    spinal cord stimulation chronic pain

    Study shows “major energy savings” can be achieved in spinal cord...

    rtms therapy georgia stillianesis

    rTMS found to be “well-accepted” for therapeutic use in psychiatric populations

    Greater outreach needed for women and minority pain patients

    First-in-human study demonstrates use of high-bandwidth wireless brain-computer interface  

    Repetitive TMS demonstrates ability to reduce suicidal thoughts and behaviours

    DRG stimulation

    Dorsal root ganglion stimulation evokes motor responses in patients with complete...

    zeto EEG study

    New study tests “first-of-its-kind” EEG device

    Medtronic

    Medtronic announces US launch of its InterStim Micro neurostimulator

    Axonics two year results ARTISAN-SNM study

    Axonics announces two-year results from its ARTISAN-SNM study

    synchron funding for stentrode

    Synchron secures funding to advance commercialisation of Stentrode

    blood test abbott

    FDA approves Abbott’s iOS-compatible app for the management of chronic pain...

    asleep surgery dbs

    Asleep surgery improves the therapeutic window for deep brain stimulation

    spinal cord stimulation explant rate

    Up to 13% of patients could have their spinal cord stimulator...

    Soterix Medical IDE depression

    Soterix wins IDE for depression treatment trial

    LivaNova RECOVER design published

    RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published

    burst spinal cord stimulation TRIUMPH

    Burst spinal cord stimulation improves psychosocial outcomes and reduces opioid usage...

    Axonics FDA approval Remote Control

    Axonics receives FDA approval for 3T full-body MRI scans

    Percept PC neurostimulator

    FDA approves Percept PC neurostimulator with BrainSense technology

    Mainstay Medical announces FDA approval of ReActiv8 neurostimulation system for chronic...

    Axonics two year results ARTISAN-SNM study

    FDA approval for Axonics’ wireless patient Remote Control with SmartMRI technology

    LivaNova RECOVER design published

    New study shows significant positive impact of vagus nerve stimulation therapy...

    Philip Kim Tim Deer

    Decision-making in intrathecal drug delivery devices “life-threatening” amid COVID-19

    Peter Staats COVID-19 nVNS

    Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...

    Educational curriculum for spinal cord stimulation developed to fill “unmet need”

    Axonics two year results ARTISAN-SNM study

    Axonics wins FDA approval for its next-generation implantable neurostimulator

    Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers

    closed-loop SCS Saluda Medical Tim Deer

    Novel intermittent dosing burst spinal cord stimulation deemed safe and efficacious...

    LivaNova RECOVER design published

    LivaNova collaborates with Verily to fuel research into vagus nerve stimulation...

    closed-loop SCS Saluda Medical Tim Deer

    New study finds high responder rates for ECAP-controlled, closed-loop spinal cord...

    10kHz painful diabetic neuropathy

    News from NANS: 10kHz safe and effective for treating painful diabetic...

    Axonics two year results ARTISAN-SNM study

    FDA approval of Axonics’ enhanced neurostimulator programmer

    stratus medical

    Stratus Medical completes private placement financing and acquisition of the NimbusRF

    News from NANS: First long-term vagus nerve stimulation implant in mice

    Medtronic logo

    Medtronic launches Efficio software to help clinicians efficiently manage targeted drug...

    DTM SCS Medtronic

    DTM spinal cord stimulation using Medtronic’s Intellis platform shows superior back...

    blood test abbott

    Abbott receives expanded indication from FDA for directional DBS to treat...

    News from NANS: BurstDR stimulation reduces negative psychological effects associated with...

    Spinal cord stimulation with DBS robotics

    News from NANS: 10kHz spinal cord stimulation deemed safe and effective...

    SPRINT peripheral nerve stimulation system demonstrates 12 months of low back...

    Efficio launch

    Medtronic receives CE mark for InterStim Micro Neurostimulator and InterStim SureScan...

    Medtronic receives CE mark approval for the Percept PC Neurostimulator deep...

    Medtronic logo

    Medtronic acquires Stimgenics, pioneer of Differential Target Multiplexed spinal cord stimulation

    saluda Medical US evoke

    Saluda Medical results of US Evoke pivotal study through 12 months...

    Axonics two year results ARTISAN-SNM study

    Axonics granted six US patents and allowed three additional patents related...

    aleva therapeutics

    Aleva Neurotherapeutics receives CE mark for its directSTIM directional Deep Brain...

    Axonics two year results ARTISAN-SNM study

    Axonics provides survey results from Physician Seminar Series showcasing the recently...

    First educational module for neuromodulation ensures field is “future-proof”

    neuropace NIH

    New data demonstrates “unprecedented” efficacy outcomes with the NeuroPace RNS system

    Pooled analysis finds dorsal root ganglion stimulation “safe and effective” for...

    neurostimulation

    Over-the-skin electrical stimulation helps provide movement in quadriplegics

    Nevro announce launch of a new medical device for the treatment...

    SNM axonics system

    Axonics announces first commercial US patient implanted with its sacral neuromodulation...

    Boston Scientific announces CE mark approval of the VERCISE Neural Navigator...

    BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous...

    insera CLEAR aspiration

    Insera announces first two stroke patients treated with its cyclical aspiration...

    interstim medtronic

    Medtronic announces FDA submission for InterStim Micro neurostimulator and SureScanTM MRI...

    Axonics two year results ARTISAN-SNM study

    Axonics provides full one-year results from ARTISAN-SNM pivotal study

    proclaim abbott

    FDA approves low-dose spinal cord stimulator for chronic pain

    Axonics FDA approval Remote Control

    Axonics announces agreement to supply sacral neuromodulation systems to leading urology...

    RECOVER

    LivaNova enrols first patient in RECOVER clinical study

    Brainstorms festival

    The Brainstorms Scientific set to host Europe’s first transdisciplinary neuroscience festival

    Stimwave launches post-market peripheral neuropathy pain relief randomised controlled trial

    saluda medical evoke

    Saluda Medical announces European commercial launch of Evoke, the ECAP-controlled, closed-loop...

    pain scores SCS trial

    Low pain scores following spinal cord stimulation trials found predictive of...

    Axonics FDA approval Remote Control

    Axonics announces US FDA approval for its sacral neuromodulation system

    Evoke Lawrence Poree INS SCS

    The clinical utility of evoked compound action potentials is echoed by...

    Medtronic CEO Omar Ishrak

    Omar Ishrak to step down as Medtronic CEO next year

    Nevro announces completion of patient enrolment in multicentre RCT of high...

    Similar success rates for anatomic and targeted lead placement for spinal...

    The first wireless spinal cord stimulator system elicits a high response...

    Placebo-controlled RCTs of spinal cord stimulation are on the rise, but...

    Stimwave announces completion of enrolment for the Tsunami placebo-controlled double-blind randomised...

    Spinal cord stimulation with DBS robotics

    The “neurosurgical robot” facilitates further research in deep brain stimulation

    NIH study to utilise NeuroPace RNS system for research on the...

    Physicians Educational Resource

    Physicians’ Education Resource releases agenda for the 1st Annual International Congress...

    neurolief

    The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE...

    EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease

    Latest FDA caution for the use of off-label drugs in intrathecal...

    saluda medical evoke

    Saluda Medical raises US$75 million equity financing from Boston Scientific and...

    BrainsWay OCD

    New published data affirms BrainsWay’s deep TMS system for the treatment...

    saluda medical medtronic

    Saluda Medical secures debt financing from Medtronic

    SNM axonics system

    Axonics announces FDA approval for the use of full-body MRI for...

    “Pain insensitive patient” may pave the way for new treatments of...

    flow depression

    Medication-free treatment for depression launches in the UK

    Saluda Medical announce three-month, 12-month and 18-month data on the Evoke...

    Key findings from a review of the indications, complications, and incidence...

    Abbott partners with NIH on BRAIN initiative to advance research for...

    Burst stimulation of the spinal cord leads to greater pain modulation...

    NeuroPace present positive data from studies of the RNS System

    Neuromod prepares for global commercialisation of Lenire tinnitus treatment

    Medtronic logo

    Medtronic’s Evolve workflow with spinal cord stimulation demonstrates effective pain relief...

    Review shows inaccuracies of deep brain stimulation data for minimally conscious...

    International Neuromodulation Society announces 14th World Congress

    Study of SPR Therapeutics’ peripheral nerve stimulation system demonstrates sustained relief...

    Welkin Health announces partnership to implement a programme to support commercialisation...

    New data show the therapeutic benefits of directional leads for use...

    Ricardo Vallejo

    Novel differential-target multiplexed technique outperforms conventional SCS

    Physicians’ Education Resource to host first annual International Congress on the...

    Less-invasive procedure helps surgeons pinpoint epilepsy surgical candidates

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Evoke: The first RCT to measure spinal cord activations in response...

    Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim

    LivaNova RECOVER design published

    CMS trial clearance for LivaNova’s vagus nerve stimulation therapy for treatment-resistant...

    SNM axonics system

    Axonics granted full-body MR-conditional CE mark for its sacral neuromodulation system

    Stimwave address patent infringement lawsuit brought by Nevro

    Real-world review reports significant reduction in pain with high-frequency 10kHz SCS

    Medtronic’s deep brain stimulation for medically-refractory epilepsy launches in the USA

    SNM axonics system

    Axonics announce positive clinical data from its ARTISAN sacral neuromodulation pivotal...

    Nevro files lawsuit for patent infringement against Stimwave

    NeuroPace announces new Category I CPT code for the RNS system

    Spectra WaveWriter spinal cord stimulator system launches in Europe

    Abbott receives CE mark of MR-conditional labelling for Infinity deep brain...

    Boston Scientific launches Vercise primary cell and Vercise Gevia deep brain...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Study finds significant reduction in pain with high-frequency 10kHz peripheral nerve...

    Completion of SURF randomised clinical trial of SCS system

    Majority of radiculopathy patients prefer burst to conventional tonic stimulation

    Companies partner for a non-invasive neuromodulation device to treat spasticity

    FDA approves Smart Programmer for the InterStim system

    FDA approval of Exablate Neuro for the treatment of tremor-dominant Parkinson’s...

    Percutaneous PNS may hold the potential to shift the chronic pain...

    Nuvectra receives full-body MR-conditional CE Mark approval for Algovita

    Nuvectra receives FDA head-only MR-conditional approval for Algovita

    Good news for gamblers: Transcranial direct current stimulation found to enhance...

    Mainstay Medical announces headline results from ReActiv8-B clinical study

    Deep brain stimulation found to yield “robust but limited” clinical benefits...

    First use of SPRINT endura peripheral nerve stimulation system to treat...

    Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...

    FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables...

    Medtronic logo

    Medtronic launches the Control Workflow to help eliminate oral opioids and...

    SPR Therapeutics awarded US$10M to develop its SPRINT peripheral nerve stimulation...

    SPR Therapeutics announces first use of SPRINT extensa dual-lead peripheral nerve...

    Coverage decision extends DRG therapy to 22 million Americans living with...

    PathMaker Neurosystems launches European clinical trial of MyoRegulator

    patients suffering from complex regional pain syndrome

    Evidence in favour of DRG stimulation builds with new study

    US FDA clears first magnetic, non-invasive device treatment for OCD

    Non-invasive brain stimulation may help symptoms of neurodegenerative ataxias

    US FDA clears non-opioid SPRINT endura and extensa peripheral nerve stimulation...

    Abbott expands its directional deep brain stimulation therapy by offering new...

    Intellis is now licensed in Canada

    Patent litigation update for Nevro–Boston Scientific case

    Preliminary results of the CRISP study suggest that intraoperative paresthesia mapping...

    Mainstay Medical announces the completion of all implants in the ReActiv8-B...

    Algovita SCS System implantations reach 2,000 in the USA

    Level I evidence provided for pain relief from 1 kHz to...

    Nuvectra issues update on US FDA and CE mark applications for...

    DBS treatment may slow the progression of parkinson’s tremor in early-stage...

    Christopher M Smith joins Neuromod Board as strategic advisor

    Adding subcutaneous nerve stimulation allows more effective low back pain relief

    Deep brain stimulation associated with a decreased risk of fall in...

    Focused ultrasound earns positive NICE guidance for treatment of essential tremor

    Deep brain stimulation showing promise for patients with mild Alzheimer’s disease...

    New clinician programmer for deep brain stimulation therapy

    NeuroPace launches next generation RNS system, the world’s only brain-computer interface...

    Self-tuning brain implant could help treat patients with Parkinson’s disease

    Final ReActiv8 results: neurostimulation safe and effective treatment for chronic low...

    The US Department for Homeland Security warns of cybersecurity weakness of...

    Study lays foundation for treating drug, alcohol addicts with noninvasive brain...

    CE mark for overactive bladder neuromodulation device

    Medtronic logo

    Medtronic receives FDA Approval for deep brain stimulation therapy for medically...

    Spinal cord stimulation and chronic pain: In the end it’s about...

    SNM axonics system

    Axonics secures US$40M financing to commercialise neuromodulation device

    Pulsante Therapy awarded prestigious Forfait Innovation package to fast-track medical innovation...

    Soin Neuroscience commences a clinical case series with Nuvectra’s Algovita spinal...

    Neurostimulation can be part of the solution to the opioid crisis

    “Shuffle” stimulation improves pain scores in pilot study

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Deep brain stimulation shows promise as treatment for Alzheimer’s disease

    Pathway R-1 registry study demonstrates Pulsante therapy effectively treats cluster headaches

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    WHISPER SCS study: therapy optimisation associated with more effective pain relief

    Spectra WaveWriter Spinal Cord Stimulator System receives FDA approval

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    FDA approves Senza II Spinal Cord Stimulation System

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

    First patient enrolled in study to assess optimised spinal cord stimulation...

    Vercise deep brain stimulation system gains FDA approval

    StimRouter Neuromodulation System eligible for increased Medicare reimbursements

    Radiofrequency treatment provides pain relief in new study

    NANS responds to California DWC order to discontinue coverage of non-opioid...

    Nevro receives CE mark for full-body MRI conditional labelling with the...

    Intellis platform receives CE mark for spinal cord and peripheral nerve...

    Aleva Neurotherapeutics raises US$13 million in latest financing round

    NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...

    FDA approves SenTiva device for treatment of epilepsy

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Closed-loop spinal cord stimulation may represent new paradigm to mitigate tolerance

    Flexible battery could revolutionise implanted devices

    FDA approves Intellis platform for chronic pain

    Evidence in favour of DRG stimulation builds with real-world data

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    No difference in pain relief between 1kHz and 10kHz spinal cord...

    MRI conditionality across spinal cord stimulation devices: the myths & science

    US FDA clears Stimwave’s full-body MRI-ready wireless peripheral nerve stimulator

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    DBS for chronic neuropathic pain efficacious at three years’ follow-up

    FDA clears Stimpod NMS460 non-invasive neuromodulation device

    SafeOp Surgical files for 10th patent, extending capabilities of its EPAD intraoperative...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Marking 50 years of spinal cord stimulation

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Transcranial stimulation and/or physical therapy improves walking speed in Parkinson’s disease

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    SureTune3 earns CE mark for deep brain stimulation therapy

    Parkinson’s disease patients first to be treated with Leksell Vantage Stereotactic...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Spinal cord stimulator implant infection rates decreasing

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    CE mark for Vercise Gevia deep brain stimulation system

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    SureTune3 deep brain stimulation software receives Health Canada licence

    Saluda Medical secures US$40 million in series D financing

    CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Higher trial-to-implant ratio found at high-volume SCS centres

    Giancarlo Barolat

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    High patient satisfaction levels for spinal cord stimulation over a 7.5-year...

    Australian Therapeutic Goods Administration approves Freedom spinal cord stimulation system

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Deep brain stimulation decreases tics in young adults with severe Tourette...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Prospective study shows good efficacy with high-frequency spinal cord stimulation in...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Low-profile multicolumn paddle lead improves access to spinal canal

    ADDRESS trial of Prometra II infusion system begins

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Deep brain stimulation treatment for chronic anorexia is safe and may...

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Individualised patient care the future of SCS

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    How do you design unbiased neuromodulation trials?

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    More research needed to show potential of neuromodulation

    Proclaim DRG Neurostimulation System introduced in Europe

    patients suffering from complex regional pain syndrome

    ACCURATE 12-month data published in Pain

    Nuvectra picks up New Product Innovation Award for SCS device

    Abbott completes the acquisition of St Jude Medical

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    New guidance on neuromodulation therapy to be published

    CE mark for full body MR conditional labelling for Proclaim Elite...

    Nevro files lawsuit for patent infringement against Boston Scientific in the...

    CE mark for Quell wearable pain relief device

    Neuronix submits neuroAD System for FDA clearance

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    Spinal cord stimulation leads to “significant improvement” in gait in Parkinson’s...

    Proclaim Elite spinal cord stimulation system earns full-body MRI compatibility labelling

    patients suffering from complex regional pain syndrome

    Southeast Pain Care uses new Axium neurostimulator for chronic pain

    Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

    St Jude Medical shareholders approve merger with Abbott

    Infinity deep brain stimulation system approved in the USA

    FDA approves BurstDR stimulation for patients with chronic pain

    Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...

    Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

    ReActiv8-A sustains performance at one year in clinical trial

    Study urges earlier consideration of spinal cord stimulation in chronic pain...

    SCS TechTalk: Innovation Starts Here

    CE mark granted to Medtronic for SureTune2 deep brain stimulation therapy

    burst spinal cord stimulation TRIUMPH

    Most patients with chronic trunk or limb pain experience “substantial” pain...

    Boston Scientific acquires Cosman Medical radiofrequency ablation manufacturer

    Cefaly releases revamped pocket-sized model of migraine headband

    Higher spinal cord stimulation frequency may reduce epileptic seizure

    Blue Cross Blue Shield denies coverage for high-frequency spinal cord stimulation...

    St Jude Medical launches Infinity deep brain stimulation system and directional...

    BlueWind Medical receives CE mark for first-to-market miniature overactive bladder wireless...

    Pulse frequency is “vital parameter” for successful spinal cord stimulation therapy

    Paraesthesia may increase attention to pain, study finds

    Nuvectra reports first quarter financial results

    Nevro releases 2016 first quarter financial results

    CE mark granted to Mainstay Medical for ReActiv8

    Boston Scientific receives US FDA approval for Precision Montage MRI spinal...

    Stimwave announces partnership with Kairuku

    burst spinal cord stimulation TRIUMPH

    Burst stimulation “generally” more effective than tonic

    FDA approves new surgical leads for Senza SCS System

    Transcranial direct current stimulation can boost language comprehension, Penn study finds

    patients suffering from complex regional pain syndrome

    First US commercial implants of Axium DRG system announced

    Neuros Medical completes interim analysis of pivotal study for post-amputation pain

    NICE provides positive guidance on gammaCore treatment for the prevention and...

    NeuroMetrix to collaborate with Premera Blue Cross to pilot Quell wearable...

    FDA clears Stimwave’s miniature StimQ peripheral nerve stimulator

    Medtronic offer first complete portfolio of full-body MR conditional neurostimulation systems

    patients suffering from complex regional pain syndrome

    FDA approves Axium Neurostimulator System for dorsal root ganglion stimulation

    FDA approves deep brain stimulation for people with Parkinson’s disease with...

    Debate: Paraesthesia-free spinal cord stimulation: The future, or a phase?

    St. Jude Medical: Returning innovation to chronic pain treatment

    Bioness StimRouter neuromodulation system clinical trial results published

    No true distinction in selection criteria between HF10 and burst stimulation

    Non-Invasive Vagus Nerve Stimulation device from electroCore reduces the incidence of...

    Medtronic launches OsteoCool radiofrequency ablation system in the US

    High-density stimulation restores efficacy in failed spinal cord stimulation therapy

    Timothy Deer

    Timothy Deer

    Stimwave Freedom-8A spinal cord stimulation system receives FDA clearance

    CMS approves transitional pass-through payment for outpatient use of Nevro’s Senza...

    Stimwave receives CE mark approval for Freedom-8A spinal cord stimulation system

    patients suffering from complex regional pain syndrome

    Long-term data confirm positive pain relief results for Axium system

    Medtronic and Samsung to collaborate on telehealth solutions for neuromodulation patients

    StimRelieve receives FDA IDE approval for a wireless stimulator system for...

    SUNBURST data demonstrates superior pain relief results for Burst Stimulation over...

    LUMINA data demonstrate 70% greater low back pain relief with Precision...

    Activa deep brain stimulation systems receive FDA approval for full-body MRI

    St Jude Medical launches spinal cord stimulation system in Europe

    FDA approves Proclaim Elite SCS System

    Monarch eTNS system by Neurosigma receives CE mark approval for treatment...

    Deep brain stimulation of the fornix (DBSf) shows benefit in the...

    NeuroPace RNS system receives ‘Most Promising New Product’ award

    CE mark application for Mainstay Medical’s ReActiv8

    Medtronic TYRX Neuro Absorbable Antibacterial Envelope now available for use with...

    Breakthrough for electrode implants in the brain

    Marcus Neuroscience Institute introduces Senza spinal cord stimulation

    Infinity deep brain stimulation system and directional DBS lead receive CE...

    Boston Scientific announces CE mark for the Vercise primary cell deep...

    Flowonix Medical announces first use of its Patient Therapy Controller

    Pain suppression in the language of nature

    New study finds that Cefaly has high efficacy for migraine prevention

    St Jude Medical receives CE mark for MRI conditional labelling of...

    Flowonix Medical Patient Therapy Controller receives FDA approval

    Paralysed men move legs with new non-invasive spinal cord stimulation

    FDA approves MR-conditional paddle lead for management of chronic pain

    US study finds DRG superior to conventional stimulation across all endpoints

    Intervention lessens severity of tinnitus

    FDA clears St Jude Medical Invisible Trial System

    Mainstay Medical announces two additional US patents

    Memorial Hermann completes first NeuroPace RNS system procedure for epilepsy patient

    Alim Louis Benabid

    Flowonix Medical and Alliance Spine and Pain Centers announce first Prometra...

    FDA approves Brio neurostimulation system

    In-home noninvasive brain stimulator may ease Parkinson’s symptoms

    The International Neuromodulation Society names a Giant of Neuromodulation

    Relief of dystonia symptoms is sustained in paediatric patients undergoing deep...

    burst spinal cord stimulation TRIUMPH

    Spinal cord stimulation for chronic pain led to decreased healthcare costs...

    New data demonstrate greater pain relief with Boston Scientific Precision Spectra...

    Stimwave receives FDA approval for IDE trial of Freedom system

    US space programme researchers develop potential nano-tools for deep brain stimulation

    Five scientific abstracts win inaugural competition at the International Neuromodulation Society...

    Axium system found to provide superior pain relief over traditional spinal...

    Weekly non-invasive brain stimulation provides long-term relief of post-stroke pain

    Invisible Trial System receives CE mark approval

    Boston Scientific launches the Precision Novi spinal cord stimulator system in...

    ‘Women in Neuromodulation’ committee created to inspire women at all levels

    Mainstay Medical gains approval to start US clinical trial of ReActiv8

    First commercial procedure of HF10 therapy performed in the USA

    Prodigy SCS approved and first implanted in Canada

    FDA approves Senza spinal cord stimulation system delivering HF10 therapy

    Flowonix Medical announces first implants of Prometra II

    St Jude Medical completes acquisition of Spinal Modulation

    St Jude Medical announces intent to acquire Spinal Modulation

    Focus on: Neuromodulation

    Ali R Rezai

    Deep brain stimulation for anorexia nervosa

    Load more

    Shelley Renowden

    Isil Saatci

    Pedro Lylyk

    NeuroNews

    Write to us
    Editorial: Jamie Bell [email protected]
    Advertising: Michael Broughton [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy